AbCellera Biologics CEO Carl Hansen's 2021 pay falls 46% to $9.1M
AbCellera Biologics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
AbCellera Biologics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at AbCellera Biologics received on average a compensation package of $5.1M, a 44% decrease compared to previous year.
Average pay of disclosed executives at AbCellera Biologics
Carl L.G. Hansen, Chief Executive Officer, received $9.1M in total, which decreased by 46% compared to 2020. 93% of Hansen's compensation, or $8.5M, was in option awards. Hansen also received $213K in bonus, $400K in salary, as well as $4.1K in other compensation.
Neil Berkley, Chief Business Officer, received a compensation package of $4.6M. 46% of the compensation package, or $2.1M, was in stock awards.
Andrew Booth, Chief Financial Officer, earned $4.3M in 2021.
Véronique Lecault, Chief Operating Officer, received $4.3M in 2021, which decreases by 28% compared to 2020.
Tryn Stimart, Chief Legal Officer, earned $3.1M in 2021, a 31% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.